These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 31841756)
1. Hereditary angioedema attack: what happens to vasoactive mediators? Ferrara AL; Bova M; Petraroli A; Veszeli N; Galdiero MR; Braile M; Marone G; Cristinziano L; Marcella S; Modestino L; Farkas H; Loffredo S Int Immunopharmacol; 2020 Jan; 78():106079. PubMed ID: 31841756 [TBL] [Abstract][Full Text] [Related]
2. Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema. Loffredo S; Bova M; Suffritti C; Borriello F; Zanichelli A; Petraroli A; Varricchi G; Triggiani M; Cicardi M; Marone G Allergy; 2016 Jul; 71(7):989-96. PubMed ID: 26873113 [TBL] [Abstract][Full Text] [Related]
3. Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor. Bova M; Suffritti C; Bafunno V; Loffredo S; Cordisco G; Del Giacco S; De Pasquale TMA; Firinu D; Margaglione M; Montinaro V; Petraroli A; Radice A; Brussino L; Zanichelli A; Zoli A; Cicardi M Allergy; 2020 Jun; 75(6):1394-1403. PubMed ID: 31860755 [TBL] [Abstract][Full Text] [Related]
4. Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1. Kajdácsi E; Jani PK; Csuka D; Varga L; Prohászka Z; Farkas H; Cervenak L J Clin Immunol; 2016 Feb; 36(2):160-70. PubMed ID: 26873707 [TBL] [Abstract][Full Text] [Related]
5. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency. Suffritti C; Zanichelli A; Maggioni L; Bonanni E; Cugno M; Cicardi M Clin Exp Allergy; 2014 Dec; 44(12):1503-14. PubMed ID: 24552232 [TBL] [Abstract][Full Text] [Related]
6. Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients. Kajdácsi E; Jandrasics Z; Veszeli N; Makó V; Koncz A; Gulyás D; Köhalmi KV; Temesszentandrási G; Cervenak L; Gál P; Dobó J; de Maat S; Maas C; Farkas H; Varga L Front Immunol; 2020; 11():794. PubMed ID: 32431708 [TBL] [Abstract][Full Text] [Related]
7. Endothelial cell activation during edematous attacks of hereditary angioedema types I and II. Kajdácsi E; Jani PK; Csuka D; Varga LÁ; Prohászka Z; Farkas H; Cervenak L J Allergy Clin Immunol; 2014 Jun; 133(6):1686-91. PubMed ID: 24522092 [TBL] [Abstract][Full Text] [Related]
8. Flow-mediated vasodilation assay indicates no endothelial dysfunction in hereditary angioedema patients with C1-inhibitor deficiency. Nebenführer Z; Szabó E; Kajdácsi E; Kőhalmi KV; Karádi I; Zsáry A; Farkas H; Cervenak L Ann Allergy Asthma Immunol; 2019 Jan; 122(1):86-92. PubMed ID: 30312677 [TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid receptor gene polymorphisms in hereditary angioedema with C1-inhibitor deficiency. Zotter Z; Nagy Z; Patócs A; Csuka D; Veszeli N; Kőhalmi KV; Farkas H Orphanet J Rare Dis; 2017 Jan; 12(1):5. PubMed ID: 28069032 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency. Andrási N; Veszeli N; Holdonner Á; Temesszentandrási G; Kőhalmi KV; Varga L; Farkas H Int Immunopharmacol; 2020 Mar; 80():106216. PubMed ID: 31982824 [TBL] [Abstract][Full Text] [Related]
11. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment. Zeerleder S; Levi M Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196 [TBL] [Abstract][Full Text] [Related]
12. Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency. Farkas H; Csuka D; Gács J; Czaller I; Zotter Z; Füst G; Varga L; Gergely P Clin Immunol; 2011 Oct; 141(1):58-66. PubMed ID: 21636327 [TBL] [Abstract][Full Text] [Related]
14. Secreted Phospholipases A Loffredo S; Ferrara AL; Bova M; Borriello F; Suffritti C; Veszeli N; Petraroli A; Galdiero MR; Varricchi G; Granata F; Zanichelli A; Farkas H; Cicardi M; Lambeau G; Marone G Front Immunol; 2018; 9():1721. PubMed ID: 30083168 [TBL] [Abstract][Full Text] [Related]
15. The role of ficolins and MASPs in hereditary angioedema due to C1-inhibitor deficiency. Csuka D; Munthe-Fog L; Skjoedt MO; Kocsis A; Zotter Z; Gál P; Varga L; Farkas H; Füst G; Garred P Mol Immunol; 2013 Jul; 54(3-4):271-7. PubMed ID: 23318225 [TBL] [Abstract][Full Text] [Related]
16. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency. Jacobs J; Neeno T Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema: From Bed to Bench. Carucci L; Bova M; Petraroli A; Ferrara AL; Sutic A; de Crescenzo G; Cordisco G; Margaglione M; Gambardella J; Spadaro G; Genovese A; Loffredo S J Investig Allergol Clin Immunol; 2020; 30(4):272-280. PubMed ID: 31599724 [TBL] [Abstract][Full Text] [Related]
18. Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH). Wedner HJ Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S14-S17. PubMed ID: 33109319 [TBL] [Abstract][Full Text] [Related]
19. Bradykinin mediated gastrointestinal edema as a cause of abdominal attacks in patients with hereditary angioedema due to C1-inhibitor deficiency. Obtulowicz P; Piotrowicz-Wojcik K; Dyga W; Stobiecki M; Popiela T; Obtulowicz K J Physiol Pharmacol; 2022 Apr; 73(2):. PubMed ID: 36193964 [TBL] [Abstract][Full Text] [Related]
20. Hereditary and acquired complement component 1 esterase inhibitor deficiency: a review for the hematologist. Cicardi M; Johnston DT Acta Haematol; 2012; 127(4):208-20. PubMed ID: 22456031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]